ot;width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0" : "width=1100"' name='viewport'/> 2020 Update in Clinical Endocrinology: ADA Standards 2020: Psychosocial issues and smoking.

Friday, August 21, 2020

ADA Standards 2020: Psychosocial issues and smoking.

PSYCHOSOCIAL ISSUES

Introduction 

  • Psychosocial screening should include:
    • Attitudes towards diabetes and treatment
    • Mood
    • General and diabetes-related QoL
    • Financial, social and emotional resources
    • Psychiatric history
  • Standarized and validated tools should be used to detect: diabetes distress, anxiety, depression, disordered eating, and cognitive capacities. 
  • Patients >=65 can be screened for depression and cognitive impairment.

Diabetes distress

  • Dfn: negative psychological reactions related to having to manage diabetes. It's mostly related to burdens of diabetes management, disease progression and complications.
  • Affects about 45% of patients
  • Should be screened with "validated tools" like PAID (problem Areas in Diabetes) or DDS (Diabetes Distress Scale), see diabetesdistress.org
  • If positive, referred to a DSMES provider, given the fact that DSMES improves it
  • If DD negatively affects diabetes management, to a mental health specialist with knowledge in diabetes.

Anxiety

  • Screen for anxiety disorders AD in people who show symptoms of anxiety including hypoglycemia unawareness with fear of hypoglycemia
  • Refer to mental health if positive screening.
  • AD affect 19.5% of people with diabetes. The most common causes are hypoglycemia, not meeting glycemic targets, injections, and diabetes complications.
  • Obsessive-compulsive disorder should be suspected in cases off attitudes toward self-management that go far beyond the usual care. 
  • Structured programs of Blood Glucose Awareness Training (BGAT) help improving glycemic control and hypoglycemia en cases of fear of hypoglycemia and hypo unawareness. BGAT are usually 8 weekly sessions in groups of 5-15 subjects.

Depression

  • It affects 25% of type 1 or type 2 diabetes. It should be yearly screened with validated measures
  • If positive screening, refer to a MH provider, its treatment improves diabetic outcomes. 
  • If depression improves, reconsider therapy, previously rejected measures like physical activity or intensive insulin regimes can be accepted now.

Disordered eating behaviour

  • The most DEBs are insulin omission in type 1 diabetes and binge eating in type 2 diabetes. 
  • Suspect DEB in cases of unexplained worsening of glycemic control and weight lose
  • Certaing drugs like GLP-1 RA may help reducing hunger in binge-eaters.

Serious mental illness

  • Schizophrenia and other serious mental illness increase the risk for diabetes and it should be routinely monitored
  • Atypical or second-generation antopsychotic drugs like olanzapine particularly raise diabetes risk 
  • Because of difficulties in self-management, a caretaker must be included in the decision-making process and diabetes treatment plan. 

SMOKING AND DIABETES

  • Advise all smokers with diabetes not to smoke or use e-cigarettes. Evedence suggests short advice against smoking is effective. In motivated patients, pharmachologic treatment is also beneficial. E-cigarettes are also harmful and not advisable.